Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

We need safe, affordable drugs to fight coronaviruses effectively.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Crisaborole may help regrow hair in children with alopecia areata.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Many patients on new leukemia drugs had mild to moderate skin reactions.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

New compounds show promise as nonsteroidal treatments for hair loss.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Upadacitinib may effectively treat resistant lichen planopilaris.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.